<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by Dhruv Bhatnagar on Medium]]></title>
        <description><![CDATA[Stories by Dhruv Bhatnagar on Medium]]></description>
        <link>https://medium.com/@dhruvbh?source=rss-35b0927a04ba------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/2*Qh0A_ewAyV1te2chKlK4Rw.jpeg</url>
            <title>Stories by Dhruv Bhatnagar on Medium</title>
            <link>https://medium.com/@dhruvbh?source=rss-35b0927a04ba------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Mon, 16 Nov 2026 23:52:09 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@dhruvbh/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[Telemedicine Opportunity in Urban India]]></title>
            <link>https://dhruvbh.medium.com/telemedicine-opportunity-in-urban-india-63de17105c44?source=rss-35b0927a04ba------2</link>
            <guid isPermaLink="false">https://medium.com/p/63de17105c44</guid>
            <category><![CDATA[telemedicine]]></category>
            <category><![CDATA[india]]></category>
            <category><![CDATA[telehealth]]></category>
            <category><![CDATA[practo]]></category>
            <category><![CDATA[virtual-healthcare]]></category>
            <dc:creator><![CDATA[Dhruv Bhatnagar]]></dc:creator>
            <pubDate>Thu, 04 Jun 2020 18:24:40 GMT</pubDate>
            <atom:updated>2021-03-12T08:15:30.987Z</atom:updated>
            <content:encoded><![CDATA[<p><em>Disclaimer:</em><strong><em> </em></strong><em>The views, thoughts, and opinions expressed in the text belong solely to the author, and not necessarily to the author’s employer, organization, committee, or other group or individuals.</em></p><p>Given the expected decrease in outpatient visits due to Covid-19, widespread smartphone and 4G access, and low Doctor-to-patient (1:1445)<a href="https://www.business-standard.com/article/pti-stories/doctor-patient-ratio-in-india-less-than-who-prescribed-norm-of-1-1000-govt-119111901421_1.html">¹</a> ratio in India — it is safe to say that Telemedicine’s time has come. While one of the most potent use cases of Telehealth is to enable medical reach in the far-flung areas-the focus of this article will be specifically Urban India defined as Tier-1,2,3 cities and regions.</p><p><strong>Index:</strong></p><ul><li>Introduction</li><li>Delivery Model</li><li>Regulations</li><li>The Addressable Market opportunity</li><li>Current players in the landscape</li><li>Business Models</li><li>Platform Dynamics</li><li>Key Opportunities and Looking ahead</li></ul><h3>Introduction:</h3><p>According to the Medical Council of India, Telemedicine is defined as:</p><p><em>“</em>The delivery of health care services, where distance is a critical factor, by all health care professionals using information and communication technologies for the exchange of valid information for the diagnosis, treatment and prevention of disease and injuries, research and evaluation, and for the continuing education of health care providers, all in the interests of advancing the health of individuals and their communities” <a href="https://www.mohfw.gov.in/pdf/Telemedicine.pdf">²</a></p><p>Another term which is often talked about is “Telehealth”. Telehealth is different from telemedicine because it refers to a broader scope of remote healthcare services than telemedicine. While telemedicine refers specifically to remote clinical services, telehealth can refer to remote non-clinical services, such as provider training, administrative meetings, and continuing medical education, in addition to clinical services.</p><h3>Delivery Model:</h3><ol><li>Asynchronous consultation over text message</li><li>Synchronous consultation over a phone call</li><li>Synchronous consultation over video call</li></ol><p>The primary devices expected to be used for such consultations are smartphones with laptops also being used in minor cases. There are some other applications including the use of specialized devices to transmit video — they are not part of the consideration for this discussion.</p><h3>Regulations:</h3><p>Given the disruptive nature of the model, a lack of clear guidelines from regulators is a common complaint across different countries in this sector. Currently, the practice is loosely governed through a mishmash of regulations relating to medicine and technology.</p><p>The Ministry of Home Affairs recently released a set of <a href="https://www.mohfw.gov.in/pdf/Telemedicine.pdf">Guidelines</a> in March 2020, just as Covid-19 begin to spread in the country.</p><p>The guidelines provide norms and protocols relating to a physician-patient relationship; issues of liability and negligence; evaluation, management and treatment; informed consent; continuity of care; referrals for emergency services; medical records; privacy and security of the patient records and exchange of information; prescribing; and reimbursement; health education and counseling.</p><p>This benefited the ecosystem in 2 ways:</p><ol><li>Legitimized the Telemedicine practice by removing ambiguities — enables trust from both the supply side (Doctors) and the demand side (patients) while ensuring Investors understand the space as well.</li><li>Allowed a Registered Medical Practitioner (RMP) in the country to consult any patient from any geographical region. This is unlike the U.S. which has strict guidelines around physicians only being able to consult patients for areas (usually a state) which they have a license for. The majority of doctors in the U.S. have a license for their state of residence only and a nationwide medical license takes years to procure. This has severely constricted the supply of doctors in the U.S. which will thankfully not be a problem in India.</li></ol><h3>The Addressable Market Opportunity in Urban India (Demand side):</h3><p>Let’s get into a bit of old school market sizing:</p><ol><li>An average person in an Urban area visits a doctor an average of <a href="https://timesofindia.indiatimes.com/india/visits-to-doctors-rise-nearly-20-in-2018/articleshow/68717879.cms">3 </a>times a year. This number includes fresh visits only and does not include follow-ups which are usually free. <em>(The assumption here is that this includes Private hospitals/clinics only and does not include Government hospitals which see much larger volumes but are subsidized and free.)</em></li><li>The understanding is that with Telemedicine -&gt; The number of total visits will be ~5 with 2 physical visits and 3 virtual visits</li><li>The average fee per physical visit at private clinics is Rs 300 ($3.5). This will go down to $2 for a Telemedicine session</li><li>Given that 40% of the Indian population lives in Urban areas now; this brings us to a <strong>Total Addressable Market (TAM) size for Telemedicine as</strong> = (1.3Bn * 0.4) * 3 visits * $2 per session =<strong>$3.12Bn per year</strong></li></ol><p>According to a report, the current market size is <a href="https://www.expresshealthcare.in/covid19-updates/transforming-indian-healthcare-via-telemedicine/418106/">$32M</a> (2020) indicating penetration of just 1% and signalling a sufficient room to grow for everyone involved</p><p>This is just the market size for consultation services. It’s fair to argue that it is possible to provide an ecosystem of services around the consultation starting from medicine delivery, diagnostic tests to medical devices (ECG, Pulse Oximeter, Blood pressure checking machines, Wearables) for Remote patient monitoring and engagement, which further strengthen the overall offering. The list of add-ons keeps on increasing if you add marketplaces around nutritional foods to it. <strong>Essentially this is a chance to create a loyalty-based medical ecosystem for all of an individual’s needs.</strong></p><h3>Current players in the landscape:</h3><p>When we talk about the landscape there are close to 20+ players in this space with players from different segments. For the majority of these except “Telehealth focused players”, Telemedicine is more of an add-on service rather than a core value proposition. We expect that to change as Covid-19 and pandemics potentially become the new normal. The different segments are:</p><ol><li>Physical Appointment players: Practo, Lybrate, Credihealth</li><li>Telehealth focused players: DocOnline, DocsApp, MediBuddy, Visit</li><li>Medicine Delivery players: MedLife, 1mg</li><li>Hospitals: Apollo Hospitals, Meenakshi Mission Hospital, and Research Centre, IVF Indira</li><li>Fitness Chains: CareFit (by Cure.Fit)</li><li>Telecom players: JioHealth Hub (partnership with iCliniq)</li></ol><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*wJruWA8DT0Pq71F5_PVxLg.png" /><figcaption><strong>India’s crowded Telemedicine space….</strong></figcaption></figure><h3>Business Models:</h3><p><strong>Direct-to-Consumer (D2C): </strong>This by-far is the most common model as telemedicine players target individuals directly.</p><ul><li>The primary revenue driver is a certain %age commission from the overall consultation fee (Total fee ranges from $1.5 — $6). There is an opportunity to earn ancillary revenue on this by offering other services such a medicine delivery, nutritional products, diagnostic test bookings, and follow-up physical appointments.</li></ul><p>Customer experience and satisfaction will be the number driver repeat customers and that is driven by the quality of doctors (supply-side). However solving the supply-side equation in the D2C model is not easy — each doctor on the platform needs to be thoroughly vetted and verified. It remains the biggest challenge, given that <a href="https://www.who.int/hrh/resources/16058health_workforce_India.pdf">57.3%</a> of India’s medical practitioners are unlicensed. This is exactly where Physical Appointment Booking companies such as Practo are at an advantage as they already understand the most trusted and respected doctors and can offer them first to consumers. Practo’s other offerings around medicine delivery and diagnostic test booking enable it to complete the consumer life cycle journey unlike any other player out there. This uniquely positions Practo as my best pick to potentially dominate the landscape in urban India.</p><p><strong>Other Potential supply-side issues:</strong> The majority of players claim to tie-up with hospitals and other medical institutions for doctor sign-ups to bring in the element of trust. This will a potential conflict later on when hospitals (realizing the opportunity) — will launch their own Telemedicine Apps (Addressed in the B2B segment) and might restrict access to their doctors on other platforms. This draws a similar parallel to the battle for content as seen in the streaming wars. Can D2C companies look at a model that involves enrolling doctors on their payroll akin to Netflix owning content? — Highly unlikely but never say never!</p><p><strong>B2B or B2B2C: </strong>In this model, players essentially sell white-label or branded software and services to hospitals, employers, or insurers through a SaaS model. Prices vary based on employee usage or physician usage as well as session volumes. Visit and Clinikk Healthcare</p><p>The supply-side issues are mitigated when serving a hospital as they get their doctors on the platform; however, they are very much relevant when working with employers.</p><h3>Platform dynamics:</h3><p>The majority of telemedicine companies are essentially transactional platforms that connect one side of the platform (users) with the other side (doctors).</p><ul><li><strong>Telemedicine platforms exhibit indirect network effects </strong>(the value that one patient gets from the addition of another doctor to the platform). This means that patients will be willing to sign up if there are enough doctors of different varieties(general physicians, orthopedics, cardiologist,etc..) on the platform and vice-versa. Once this population is large enough, a D2C company can use it in multiple ways. It can market to enterprises as an attractive way to bring 24/7 access to their employees. It can also use the data collected to provide reports and analytics to both doctors and patients or launch products of different kinds in segments they see picking pace. However, a massive user base is necessary but not sufficient to drive long term success.</li><li>T<strong>elemedicine platforms also experience multi-homing</strong>, which means both users and doctors can sign up with different telemedicine platforms at no-cost (most of the different players allow doctors to list their practice for free). Given the fact that there is little differentiation between competitors, with pretty much the same cost for a consultation: there is significant competitor threat which prevents a winner-take-all scenario in this space.</li></ul><p><strong>What can players do to respond to these market conditions?</strong></p><p>There is a clear need to bring in <strong>differentiation into the platforms</strong> which can be done by:</p><ol><li>Offering a superior customer experience (either enabled by technology or the quality of doctors on the platform)</li><li>Offer complementary offerings like medicine delivery and diagnostics test booking (3–4 companies already offer this)</li><li>Partner exclusively with other health-focused platforms like Samsung Health / Apple Health to drive demand</li></ol><p>However, if companies are not able to bring in differentiation, Telehealth will increasingly be treated like a commodity where employers and patients choose the lowest cost provider.</p><h3>Key Opportunities and Looking Ahead:</h3><p>Given the 0.01% penetration in Urban centers alone — there will be enough opportunities for all players to expand. However, I expect mergers and acquisitions in this space going forward as physician and customer capture will lead to a reduction in acquisition costs at both the supply side and demand side.</p><p>While this post addresses the opportunity in Urban India; the elephant in the room and the geographical segment for which Telemedicine will deliver the maximum value is the rural segment of the country — where approximately 60% of the population of India resides. While internet (rural internet users growing by <a href="https://tech.economictimes.indiatimes.com/news/internet/rural-india-to-drive-internet-users-in-india-report/75560221#:~:text=Kantar%20estimates%20that%20there%20are,users%20in%20rural%20India%20currently.&amp;text=It%20further%20said%20there%20had,growth%20of%2024%25%20in%202019.">45</a>% y-o-y) and smartphone penetration are smaller issues — consumer education and getting them accustomed to using smartphones as a medium for consultation will take time. I believe an offline(brick and mortar)+ online presence is essential to crack this market (<a href="https://www.tattvan.com/">Tattvan </a>is a company actively working on the rural market — connecting rural patients to experience doctors from metros). Rural segment and the opportunities there merit a separate post which I hope to address in the future.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=63de17105c44" width="1" height="1" alt="">]]></content:encoded>
        </item>
    </channel>
</rss>